Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands |
Sep. 30, 2017 |
Dec. 31, 2016 |
| ASSETS |
|
|
| Cash and cash equivalents (Note 2) |
$ 3,897
|
$ 441
|
| Marketable securities, available for sale |
23,641
|
|
| Escrow receivable, current |
2,500
|
|
| Accounts receivable, net (Note 2) |
1,113
|
5,770
|
| Inventory (Note 2) |
1,992
|
2,736
|
| Prepaid expenses and other current assets (Note 2) |
568
|
680
|
| Assets held for sale (Note 3) |
22
|
|
| Total current assets |
33,733
|
9,627
|
| Property, plant and equipment, net of accumulated depreciation of $5,369 and $5,134, respectively (Note 2) |
2,849
|
3,175
|
| Escrow receivable |
2,500
|
|
| Total assets |
39,082
|
12,802
|
| LIABILITIES |
|
|
| Secured promissory notes, net (Note 4) |
|
1,490
|
| Accounts payable |
503
|
2,156
|
| Accrued advertising and other allowances (Note 2) |
1,288
|
2,805
|
| Other current liabilities |
322
|
389
|
| Due to Mylan, Inc. and affiliates (Note 3) |
319
|
|
| Total current liabilities |
2,432
|
6,840
|
| COMMITMENTS AND CONTINGENCIES (Note 7) |
|
|
| STOCKHOLDERS' EQUITY |
|
|
| Preferred stock, authorized 1,000,000, $.0005 par value, no shares issued (Note 5) |
|
|
| Common stock, $.0005 par value; authorized 50,000,000; issued: 27,046,593 and 26,313,593 shares, respectively (Note 5) |
13
|
13
|
| Additional paid-in-capital |
57,347
|
56,378
|
| Retained earnings (Accumulated deficit) |
21,869
|
(19,687)
|
| Accumulated comprehensive loss |
(35)
|
|
| Treasury stock, at cost, 14,618,132 and 9,232,817 shares (Note 5) |
(42,544)
|
(30,742)
|
| Total stockholders' equity |
36,650
|
5,962
|
| Total liabilities and stockholders' equity |
$ 39,082
|
$ 12,802
|